Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Defendant's Knowledge of Reexamination Certificate May Constitute "Objective Rec
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Re: fungo

posted on Sep 30, 2009 06:16PM

Once potential infringers have been notified of the re-examination outcome, which will include the T3, the prospect of triple damages comes into play.

Something more substantial than an "arrow" in my very humble opinion.

.

.

Be well

5 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply